Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Peripheral targeting of inhaled rhDNase in stable cystic fibrosis patients
2007-000935-25Phase 4Active
- Sponsor
- Erasmus MC Sophia Children's Hospital
- Start
- Apr 2007
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial of dornase alfa in cystic fibrosis (CF) (2 arms), sponsored by Erasmus MC Sophia Children's Hospital. Primary endpoint: Change in FEF75. Started Apr 2007; status: active.
02
Drugs
dornase alfa
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on 2007-000935-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-000935-25.